Delcath Systems - 2005 News Archive

2005 Archive

December 16, 2005
Delcath Systems Announces Extension of Warrants

December 8, 2005
Delcath Receives Additional U.S. Patent for Cancer Treatment System

December 1, 2005
Delcath Systems Announces Listing of Warrants

November 28, 2005
Delcath Completes $2.5 Million Private Placement

November 21, 2005
Delcath Receives Canadian Patent for Novel Apparatus and Method for Isolated Pelvic Perfusion

November 1, 2005
Delcath Systems Retains KCSA Worldwide as Corporate Communications Counsel

June 15, 2005
Delcath Reports on 2005 Annual Meeting

June 9, 2005
Mid-Year 2005 Letter to Delcath Shareholders

May 24, 2005
NCI'S Report on Initial Study of Delcath System in Current Issue of Journal of Clinical Oncology

May 11, 2005
Delcath Receives Fast-Track Status from U.S. FDA for High Dose Cancer Treatment with Melphalan

May 7, 2005
NCI Researchers Report Survival and Tumor Results With Delcath Cancer Therapy

March 1, 2005
NCI to Present Treatment Experience With Delcath System at Oncology Symposium

January 31, 2005
National Cancer Institute Reports Encouraging Results With Delcath Cancer Therapy

Delcath News

June 13, 2007
Delcath Fulfills Nasdaq Independent Director and Audit Committee Requirements With Addition of Two New Directors

June 5, 2007
Delcath Updates Clinical Trials

June 5, 2007
Jonathan J. Lewis, MD Joins Delcath's Board of Directors

May 30, 2007

Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Center

May 24, 2007

Delcath Systems Names Laura A. Philips to Board of Directors

May 24, 2007

Delcath Systems Adds Two Executives

May 17, 2007

Delcath Systems Announces Presentation of Data at World Conference on Interventional Oncology

May 16, 2007
Delcath Systems Issues CEO Letter to Shareholders

May 10, 2007
DELCATH SYSTEMS FILES FIRST QUARTER 2007 10-Q AND SHELF REGISTRATION

April 17, 2007
Delcath Systems Announces Board Resignations

April 10, 2007
DELCATH SYSTEMS ENTERS MODIFICATION AGREEMENT WITH LADDCAP AND MODIFIES STOCKHOLDER RIGHTS PLAN

Stock Quote

Delcath stock tracker

Most recent trade:$1.22

Today's Change:0.00

(Prices delayed up to 20 minutes.)